Mucosal protective agents in the long-term management of gastric ulcer.
D000535:Aluminum / Q000008:administration & dosage / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000009:adverse effects / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001729:Bismuth / Q000009:adverse effects / Q000627:therapeutic use; D002229:Carbenoxolone / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D002927:Cimetidine / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D006035:Glycyrrhiza; D006801:Humans; D008276:Magnesium Hydroxide; D010936:Plant Extracts / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010946:Plants, Medicinal; D012008:Recurrence; D017693:Sodium Bicarbonate; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D013392:Sucralfate
D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D010936:Plant Extracts; C002792:aluminum hydroxide, bismuth subnitrate, deglycyrrhizinised liquorice, magnesium carbonate, sodium bicarbonate drug combination; D013392:Sucralfate; D000536:Aluminum Hydroxide; D002927:Cimetidine; D017693:Sodium Bicarbonate; D000535:Aluminum; D002229:Carbenoxolone; D008276:Magnesium Hydroxide; D001729:Bismuth